Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: PFE

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

FDA Authorizes Pfizer/BioNTech And Moderna’s Bivalent COVID Shots For 6 Months Old

By Vandana Singh
Today, 8:04 AM
The FDA has authorized COVID-19 shots from Moderna Inc (NASDAQ:MRNA) and Pfizer Inc (NYSE:PFE)/ BioNTech SE (NASDAQ:BNTX) targeting the original coronavirus and Omicron sub-variants…

BNTX

Read More
7 minute read
  • Biotech
  • FDA
  • General
  • News

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization For Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine In Children Under 5 Years

By Benzinga Newsdesk
Today, 8:04 AM
Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series Consistent COVID-19 hospitalization rates in this age group coupled with an overall surge in respiratory illnesses among children

BNTX

Read More
1 minute read
  • FDA
  • News

FDA Authorizes Updated (bivalent) Covid-19 Vaccines For Children Down To 6 Months Of Age

By Benzinga Newsdesk
Today, 8:04 AM
-Reuters

AZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • Movers
  • News
  • Trading Ideas

Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac

By Vandana Singh
Today, 8:04 AM
U.S. District Judge Robin Rosenberg in Florida has dismissed about 50,000 claims associated with GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE), Sanofi SA (NASDAQ:SNY), and Boehringer Ingelheim, claiming…

GSK

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

After Famed COVID-19 Pill, Pfizer Inks Research Pact For Another Antiviral Candidate

By Vandana Singh
Today, 8:04 AM
Pfizer Inc (NYSE:PFE) and Clear Creek Bio Inc announced a research collaboration and exclusive license agreement to advance the discovery and development of…

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

UK’s Regulatory Agency Backs Pfizer/BioNTech’s COVID-19 Vaccine For Youngest Kids

By Vandana Singh
Today, 8:04 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) authorized the vaccine – made by Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for children aged…

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Legal
  • News

GSK, Pfizer, Sanofi, Boehringer Ingelheim Defeat Thousands Of U.S. Lawsuits Over Zantac Cancer Claims; Cases In Federal Court Will End While Others Continue In State Courts

By Benzinga Newsdesk
Today, 8:04 AM
- Court Order

GSK

Read More
1 minute read
  • General
  • Health Care
  • News

Pfizer Files Countersuit Against Moderna In Patent Litigation Over COVID-19 Vaccine

By Michael Horton
Today, 8:04 AM
-Reuters

BNTX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

Pfizer And BioNTech Submit Application To U.S. FDA For Emergency Use Authorization Of Omicron Ba.4/Ba.5-adapted Bivalent COVID-19 Vaccine In Children Under 5 Years

By Benzinga Newsdesk
Today, 8:04 AM
- Reuters

BNTX

Read More
4 minute read
  • Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights
Today, 8:04 AM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

BDX

Posts navigation

Previous 1 … 13 14 15 … 160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service